Cost-effectiveness of precision molecular diagnostic tests for stage II colorectal cancer

BACKGROUND: In colorectal cancer, inappropriate use of adjuvant chemotherapies may lead to significant increases in healthcare costs and harms to patients. Genome-based interventions are being increasingly used in the stratification of patients according to their risk profiles. However, earlier cost...

Descripción completa

Detalles Bibliográficos
Autores principales: Chaudhari, Vivek S., Issa, Amalia M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9816824/
https://www.ncbi.nlm.nih.gov/pubmed/36618812
http://dx.doi.org/10.21037/atm-2022-77

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9816824/
https://www.ncbi.nlm.nih.gov/pubmed/36618812
http://dx.doi.org/10.21037/atm-2022-77

Ejemplares similares